CODX
Co-Diagnostics, Inc. Common Stock
NASDAQ: CODX · HEALTHCARE · MEDICAL DEVICES
$1.53
-6.13% today
Updated 2026-04-29
Market cap
$5.94M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-35.25
Dividend yield
—
52W range
$1 – $47
Volume
1.5M
Co-Diagnostics, Inc. Common Stock (CODX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-28.2%
Last 4 quarters
Revenue YoY growth
+76.7%
Most recent quarter
EPS YoY growth
-1074.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-16.4%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-4.44 | -3314.5% | $2.31 | $2.59 | +12.1% |
| 2025-11-13 | $-0.16 | +0.0% | $0.40 | $0.33 | -16.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.13 | $-4.44 | -3314.5% | $263922.00 | +76.7% |
| 2025-09-30 | $-0.16 | $-0.16 | +0.0% | $145380.00 | -77.3% |
| 2025-06-30 | $-0.66 | $-0.23 | +65.2% | $162910.00 | -93.9% |
| 2025-03-31 | $-0.33 | $-0.26 | +22.0% | $50277.00 | -80.1% |
| 2024-12-31 | $-0.34 | $-0.38 | -11.1% | $149325.00 | -95.8% |
| 2024-09-30 | $-0.33 | $-0.32 | +3.0% | $641141.00 | -73.9% |
| 2024-06-30 | $-0.34 | $-0.14 | +58.8% | $2.66M | +1243.2% |
| 2024-03-31 | $-0.21 | $-0.31 | -47.6% | $252745.00 | -58.0% |
| 2023-12-31 | $-0.20 | $-0.50 | -150.0% | $3.56M | — |
| 2023-09-30 | $-0.29 | $-0.20 | +31.0% | $2.46M | — |
| 2023-06-30 | $-0.24 | $-0.31 | -29.2% | $197806.00 | — |
| 2023-03-31 | $-0.22 | $-0.20 | +9.1% | $601957.00 | — |
| 2022-12-31 | $-0.15 | $-0.68 | -353.3% | — | — |
Frequently asked questions
Has Co-Diagnostics, Inc. Common Stock beaten earnings estimates?
Co-Diagnostics, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -28.2% over the last 4 quarters.
How does CODX stock react to earnings?
CODX stock has moved an average of -2.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Co-Diagnostics, Inc. Common Stock's revenue growth rate?
Co-Diagnostics, Inc. Common Stock reported year-over-year revenue growth of +76.7% in its most recent quarter, with EPS growing -1074.9% year-over-year.